Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Discovery of in vivo Chemical Probes for the Nervous…

U.S. National Institutes of Health·United States of America

Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)

Closes 3/5/2027$250k – $2.5MGrants Notice
Get bids like this by emailBid source

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to support investigators who have the interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds. Through this NOFO, NIH wishes to stimulate research in: • Discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Eye Institute (NEI), and/or National Institute on Aging (NIA) • Discovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes.

Attached files

Contact

Paul G. Grothaus, Ph.D.(Scientific/Research Contact or Grants Management Contact)

[email protected] or other email addresses depending on the specific contact.

(240) 688-6634 or other phone numbers depending on the specific contact.

Key dates

Opened
9/29/2025
Closes
3/5/2027
Projected award
4/5/2027
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-27-081

Budget estimate

$250,000 – $2,500,000

The budget for this grant is likely to be in the range of $250,000 to $500,000 per year for 1-5 years, considering the typical funding amounts for R01 research grants. However, the exact budget amount will depend on the specific proposal, the applicant's qualifications, and the NIH's funding priorities. Factors that may influence the likely payment range include the scope of the project, the number of personnel involved, and the equipment and resources required.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 90%

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

87% match

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/17/2021

U.S. National Institutes of Health·United States of America

87% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. National Institutes of Health·United States of America

86% match

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Closes 7/2/2027Opened 7/5/2023

U.S. National Institutes of Health·United States of America

86% match

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/12/2021

U.S. National Institutes of Health·United States of America

86% match

Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)

Closes 1/7/2028Opened 1/13/2023

U.S. National Institutes of Health·United States of America

86% match

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/12/2021

U.S. National Institutes of Health·United States of America

85% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

85% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

85% match

Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 1/6/2023

U.S. National Institutes of Health·United States of America

84% match

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/21/2022

U.S. National Institutes of Health·United States of America

84% match

Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)

Closes 5/7/2029Opened 9/15/2025

U.S. National Institutes of Health·United States of America

84% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 6/17/2027Opened 8/13/2026

U.S. National Institutes of Health·United States of America

84% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

84% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

84% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

84% match

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

Closes 1/28/2027Opened 2/23/2024

U.S. National Institutes of Health·United States of America

84% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

83% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

83% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

83% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

83% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025

U.S. National Institutes of Health·United States of America

83% match

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Closes 11/18/2027Opened 11/20/2024

U.S. National Institutes of Health·United States of America

83% match

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

83% match

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 10/28/2024